MedPath

Yeungnam University College of Medicine

🇰🇷South Korea
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

30

Active:0
Completed:14

Trial Phases

3 Phases

Phase 3:1
Phase 4:3
Not Applicable:22

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (26 trials with phase data)• Click on a phase to view related trials

Not Applicable
22 (84.6%)
Phase 4
3 (11.5%)
Phase 3
1 (3.8%)

Prospective triAl of Modified Treat-and-extend Regimens With BroLucizumab in pachychOroid Neovasculopathy

Phase 3
Not yet recruiting
Conditions
Age-Related Macular Degeneration
Pachychoroid Neovasculopathy
Interventions
First Posted Date
2023-01-05
Last Posted Date
2023-01-05
Lead Sponsor
Yeungnam University College of Medicine
Target Recruit Count
36
Registration Number
NCT05672979

Sevoflurane and Propofol for Botulinum Toxin Injection

Not Applicable
Withdrawn
Conditions
Cerebral Palsy
Interventions
First Posted Date
2022-08-17
Last Posted Date
2023-02-15
Lead Sponsor
Yeungnam University College of Medicine
Registration Number
NCT05505123
Locations
🇰🇷

Yeungnam University Medical Center, Daegu, Korea, Republic of

A Postoperative Sore Throat After Lumbar Spine Surgery in the Prone Position

Not Applicable
Conditions
Post Operative Sore Throat
Interventions
First Posted Date
2022-04-26
Last Posted Date
2022-04-26
Lead Sponsor
Yeungnam University College of Medicine
Target Recruit Count
104
Registration Number
NCT05345574
Locations
🇰🇷

Eun kyung Choi, Daegu, Korea (the Republic Of), Korea, Republic of

Renal Oxygen Saturation During Off-pump Coronary Artery Bypass Graft Surgery

Completed
Conditions
Acute Kidney Injury
First Posted Date
2020-12-22
Last Posted Date
2023-02-14
Lead Sponsor
Yeungnam University College of Medicine
Target Recruit Count
46
Registration Number
NCT04679337
Locations
🇰🇷

Yeungnam University Medical Center, Daegu, Korea, Republic of

Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema

Phase 4
Conditions
Diabetic Retinopathy
Interventions
First Posted Date
2020-06-26
Last Posted Date
2020-06-26
Lead Sponsor
Yeungnam University College of Medicine
Target Recruit Count
49
Registration Number
NCT04448496
Locations
🇰🇷

Dong-A University Hospital, Busan, Korea, Republic of

🇰🇷

Maryknoll Medical Center, Busan, Korea, Republic of

🇰🇷

Gyeongsang National University Changwon Hospital, Changwon, Korea, Republic of

and more 4 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.